Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

74 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Impact of hormonal biomarkers on response to hormonal therapy in advanced and recurrent endometrial cancer.
van Weelden WJ, Lalisang RI, Bulten J, Lindemann K, van Beekhuizen HJ, Trum H, Boll D, Werner HMJ, van Lonkhuijzen LRCW, Yigit R, Forsse D, Witteveen PO, Galaal K, van Ginkel A, Bignotti E, Weinberger V, Sweegers S, Kroep JR, Cabrera S, Snijders MPLM, Inda MA, Eriksson AGZ; European Network for Individualized Treatment in Endometrial Cancer; Krakstad C, Romano A, van de Stolpe A, Pijnenborg JMA. van Weelden WJ, et al. Among authors: van ginkel a, van de stolpe a, van beekhuizen hj, van lonkhuijzen lrcw. Am J Obstet Gynecol. 2021 Oct;225(4):407.e1-407.e16. doi: 10.1016/j.ajog.2021.05.007. Epub 2021 May 19. Am J Obstet Gynecol. 2021. PMID: 34019887 Free article.
Selection of personalized patient therapy through the use of knowledge-based computational models that identify tumor-driving signal transduction pathways.
Verhaegh W, van Ooijen H, Inda MA, Hatzis P, Versteeg R, Smid M, Martens J, Foekens J, van de Wiel P, Clevers H, van de Stolpe A. Verhaegh W, et al. Among authors: van ooijen h, van de wiel p, van de stolpe a. Cancer Res. 2014 Jun 1;74(11):2936-45. doi: 10.1158/0008-5472.CAN-13-2515. Epub 2014 Apr 2. Cancer Res. 2014. PMID: 24695361 Free article.
Estrogen Receptor Pathway Activity Score to Predict Clinical Response or Resistance to Neoadjuvant Endocrine Therapy in Primary Breast Cancer.
Inda MA, Blok EJ, Kuppen PJK, Charehbili A, den Biezen-Timmermans EC, van Brussel A, Fruytier SE, Meershoek-Klein Kranenbarg E, Kloet S, van der Burg B, Martens JWM, Sims AH, Turnbull AK, Dixon JM, Verhaegh W, Kroep JR, van de Velde CJH, van de Stolpe A. Inda MA, et al. Among authors: van de stolpe a, van brussel a, van der burg b, van de velde cjh. Mol Cancer Ther. 2020 Feb;19(2):680-689. doi: 10.1158/1535-7163.MCT-19-0318. Epub 2019 Nov 14. Mol Cancer Ther. 2020. PMID: 31727690
Oestrogen receptor pathway activity is associated with outcome in endometrial cancer.
van Weelden WJ, van der Putten LJM, Inda MA, van Brussel A, Snijders MPLM, Schriever LMM, Bulten J, Massuger LFAG, van de Stolpe A, Pijnenborg JMA. van Weelden WJ, et al. Among authors: van de stolpe a, van brussel a, van der putten ljm. Br J Cancer. 2020 Sep;123(5):785-792. doi: 10.1038/s41416-020-0925-4. Epub 2020 Jun 8. Br J Cancer. 2020. PMID: 32507853 Free PMC article.
Functional estrogen receptor signaling pathway activity in high-grade serous ovarian carcinoma as compared to estrogen receptor protein expression by immunohistochemistry.
van der Ploeg P, van Lieshout LAM, van de Stolpe A, Bosch SL, Lentjes-Beer MHFM, Bekkers RLM, Piek JMJ. van der Ploeg P, et al. Among authors: van de stolpe a, van lieshout lam. Cell Oncol (Dordr). 2021 Aug;44(4):951-957. doi: 10.1007/s13402-021-00600-5. Epub 2021 Mar 16. Cell Oncol (Dordr). 2021. PMID: 33723801 Free PMC article.
Heterogeneity in Signaling Pathway Activity within Primary and between Primary and Metastatic Breast Cancer.
Inda MA, van Swinderen P, van Brussel A, Moelans CB, Verhaegh W, van Zon H, den Biezen E, Bikker JW, van Diest PJ, van de Stolpe A. Inda MA, et al. Among authors: van de stolpe a, van zon h, van brussel a, van swinderen p, van diest pj. Cancers (Basel). 2021 Mar 16;13(6):1345. doi: 10.3390/cancers13061345. Cancers (Basel). 2021. PMID: 33809754 Free PMC article.
Functional estrogen receptor signal transduction pathway activity and antihormonal therapy response in low-grade ovarian carcinoma.
Hendrikse CSE, van der Ploeg P, van de Kruis NMA, Wilting JHC, Oosterkamp F, Theelen PMM, Lok CAR, de Hullu JA, Smedts HPM, Vos MC, Pijlman BM, Kooreman LFS, Bulten J, Lentjes-Beer MHFM, Bosch SL, van de Stolpe A, Lambrechts S, Bekkers RLM, Piek JMJ. Hendrikse CSE, et al. Among authors: van de stolpe a. Cancer. 2023 May 1;129(9):1361-1371. doi: 10.1002/cncr.34661. Epub 2023 Mar 3. Cancer. 2023. PMID: 36867576 Free article.
74 results